{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:33:44Z","timestamp":1778049224562,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00432-019-02965-5","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T09:16:10Z","timestamp":1562577370000},"page":"2335-2342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?"],"prefix":"10.1007","volume":"145","author":[{"given":"Christian Guido","family":"Ruf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Borck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Anheuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cord","family":"Matthies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-6364","authenticated-orcid":false,"given":"Tim","family":"Nestler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-2716","authenticated-orcid":false,"given":"Hendrik","family":"Isbarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-7956","authenticated-orcid":false,"given":"Klaus-Peter","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"2965_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","volume":"68","author":"P Albers","year":"2015","unstructured":"Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, Nicolai N, Oldenburg J (2015) Guidelines on testicular cancer: 2015 update. Eur Urol 68:1054\u20131068","journal-title":"Eur Urol"},{"key":"2965_CR2","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1093\/annonc\/mdu437","volume":"25","author":"J Aparicio","year":"2014","unstructured":"Aparicio J, Maroto P, Garc\u00eda del Muro X, S\u00e1nchez-Mu\u00f1oz A, Gum\u00e0 J, Margel\u00ed M, S\u00e1enz A, Sagastibelza N, Castellano D, Arranz JA, Herv\u00e1s D, Bast\u00fas R, Fern\u00e1ndez-Aramburo A, Sastre J, Terrasa J, L\u00f3pez-Brea M, Dorca J, Almenar D, Carles J, Hern\u00e1ndez A, Germ\u00e0 JR (2014) Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG). Ann Oncol 25:2173\u20132178","journal-title":"Ann Oncol"},{"issue":"3","key":"2965_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/andr.12177","volume":"4","author":"M Bandak","year":"2016","unstructured":"Bandak M, J\u00f8rgensen N, Juul A, Vogelius IR, Lauritsen J, Kier MG, Mortensen MS, Glovinski P, Daugaard G (2016) Testosterone deficiency in testicular cancer survivors\u2014a systematic review and meta-analysis. Andrology 4(3):382\u2013388","journal-title":"Andrology"},{"issue":"1","key":"2965_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/bju.14686","volume":"124","author":"C Berghen","year":"2019","unstructured":"Berghen C, Albersen M, Blanchard P, Bossi A, Briganti A, Cozzarini C, Decaestecker K, Fonteyne V, Haustermans K, Joniau S, Lim Joon D, Khoo V, Nguyen PL, Ost P, Villeirs G, Vulsteke C, Zietman A, De Meerleer G (2019) Readressing the rationale of irradiation in Stage I seminoma guidelines: a critical essay. BJU Int 124(1):35\u201339","journal-title":"BJU Int"},{"issue":"5474","key":"2965_CR5","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/bmj.2.5474.1327","volume":"2","author":"WM Brown","year":"1965","unstructured":"Brown WM, Doll R (1965) Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 2(5474):1327\u20131332","journal-title":"Br Med J"},{"issue":"9","key":"2965_CR6","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/annonc\/mdv254","volume":"26","author":"C Chau","year":"2015","unstructured":"Chau C, Cathomas R, Wheater M, Klingbiel D, Fehr M, Bennett J, Markham H, Lee C, Crabb SJ, Geldart T (2015) Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ cell tumour: Results from a 17\u00a0year UK experience. Ann Oncol 26(9):1865\u20131870","journal-title":"Ann Oncol"},{"key":"2965_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0090-4295(99)00376-3","volume":"55","author":"K-P Dieckmann","year":"2000","unstructured":"Dieckmann K-P, Br\u00fcggeboes B, Pichlmeier U, K\u00fcster J, M\u00fcllerleile U, Bartels H (2000) Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology 55:102\u2013106","journal-title":"Urology"},{"issue":"4","key":"2965_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000443214","volume":"96","author":"KP Dieckmann","year":"2016","unstructured":"Dieckmann KP, Dralle-Filiz I, Heinzelbecker J, Matthies C, Bedke J, Ellinger J, Sommer J, Haben B, Souchon R, Anheuser P, Pichlmeier U (2016) Seminoma clinical stage 1\u2014patterns of care in Germany. Urol Int 96(4):390\u2013398","journal-title":"Urol Int"},{"issue":"4","key":"2965_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1159\/000488284","volume":"100","author":"KP Dieckmann","year":"2018","unstructured":"Dieckmann KP, Richter-Simonsen H, Kulejewski M, Ikogho R, Zecha H, Anheuser P, Pichlmeier U (2018) Testicular germ-cell tumours: a descriptive analysis of clinical characteristics at first presentation. Urol Int 100(4):409\u2013419","journal-title":"Urol Int"},{"issue":"30","key":"2965_CR10","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","volume":"31","author":"C Fung","year":"2013","unstructured":"Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB (2013) Solid tumors after chemotherapy or surgery for testicular nonseminoma: a Population-Based Study. J Clin Oncol 31(30):3807\u20133814","journal-title":"J Clin Oncol"},{"issue":"24","key":"2965_CR11","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1200\/JCO.2017.77.4174","volume":"36","author":"HJ Groot","year":"2018","unstructured":"Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Kl\u00fcmpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, J\u00f3\u017awiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M (2018) Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era. J Clin Oncol 36(24):2504\u20132513","journal-title":"J Clin Oncol"},{"issue":"7","key":"2965_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s00120-011-2556-0","volume":"50","author":"M Hartmann","year":"2011","unstructured":"Hartmann M, Krege S, Souchon R, De Santis M, Gillessen S, Cathomas R (2011) Nachsorge von Patienten mit Hodentumoren. Interdisziplin\u00e4re evidenzbasierte Empfehlungen. [Follow-up of testicular germ cell cancer patients: Interdisciplinary evidence-based recommendations]. Urologe A 50(7):830\u2013835","journal-title":"Urologe A"},{"key":"2965_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1259\/0007-1285-57-679-597","volume":"57","author":"JH Hay","year":"1984","unstructured":"Hay JH, Duncan W, Kerr GR (1984) Subsequent malignancies in patients irradiated for testicular tumours. Br J Radiol 57:597\u2013602","journal-title":"Br J Radiol"},{"key":"2965_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/bjc.1992.164","volume":"65","author":"A Horwich","year":"1992","unstructured":"Horwich A, Alsanjari N, Hern RA, Nicholls J, Dearnaley DP, Fisher C (1992) Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 65:775\u2013778","journal-title":"Br J Cancer"},{"key":"2965_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/bjc.2013.551","volume":"110","author":"A Horwich","year":"2014","unstructured":"Horwich A, Fossa SD, Huddart R, Dearnaley DP, Stenning S, Aresu M, Bliss JM, Hall E (2014) Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma. Br J Cancer 110:256\u2013263","journal-title":"Br J Cancer"},{"issue":"12","key":"2965_CR16","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jamaoncol.2016.3651","volume":"2","author":"MG Kier","year":"2016","unstructured":"Kier MG, Hansen MK, Lauritsen J, Mortensen MS, Bandak M, Agerbaek M, Holm NV, Dalton SO, Andersen KK, Johansen C, Daugaard G (2016) Second malignant neoplasms and cause of death in patients with germ cell cancer: a Danish Nationwide Cohort Study. JAMA Oncol 2(12):1624\u20131627","journal-title":"JAMA Oncol"},{"issue":"5","key":"2965_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1464-410X.2011.10424.x","volume":"109","author":"D Lewinshtein","year":"2012","unstructured":"Lewinshtein D, Gulati R, Nelson PS, Porter CR (2012) Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma. BJU Int 109(5):706\u2013712","journal-title":"BJU Int"},{"key":"2965_CR18","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","volume":"66","author":"MS Mortensen","year":"2014","unstructured":"Mortensen MS, Lauritsen J, Gundgaard MG, Agerb\u00e6k M, Holm NV, Christensen IJ, von der Maase H, Daugaard G (2014) A nationwide cohort study of stage I seminoma patients followed on a surveillance program. Eur Urol 66:1172\u20131178","journal-title":"Eur Urol"},{"issue":"1","key":"2965_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.17886\/RKI-GBE-2017-008","volume":"2","author":"H Neuhauser","year":"2017","unstructured":"Neuhauser H, Kuhnert R, Born S (2017) 12 Monats Pr\u00e4valenz von Bluthochdruck in Deutschland. J Health Monitoring 2(1):57\u201363. \n                    https:\/\/doi.org\/10.17886\/RKI-GBE-2017-008","journal-title":"J Health Monitoring"},{"key":"2965_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s001200050226","volume":"37","author":"G N\u00f6st","year":"1998","unstructured":"N\u00f6st G, Lipsky H, W\u00fcrnschimmel E (1998) Carboplatinmonotherapie im klinischen Stadium I des Seminoms. Eine akzeptable Alternative? Urologe A 37:629\u2013634","journal-title":"Urologe A"},{"key":"2965_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/annonc\/mdu514","volume":"26","author":"J Oldenburg","year":"2015","unstructured":"Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Foss\u00e5 SD, Germ\u00e0-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Tandstad T (2015) Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 26:833\u2013838","journal-title":"Ann Oncol"},{"key":"2965_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","volume":"366","author":"RT Oliver","year":"2005","unstructured":"Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP, Collaborators MTcatE (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293\u2013300","journal-title":"Lancet"},{"issue":"8","key":"2965_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","volume":"29","author":"RT Oliver","year":"2011","unstructured":"Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP (2011) Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982 study (ISRCTN27163214). J Clin Oncol 29(8):957\u2013962","journal-title":"J Clin Oncol"},{"key":"2965_CR24","doi-asserted-by":"publisher","first-page":"606.e1","DOI":"10.1016\/j.urolonc.2017.06.051","volume":"35","author":"HD Patel","year":"2017","unstructured":"Patel HD, Srivastava A, Alam R, Joice GA, Schwen ZR, Semerjian A, Allaf ME, Pierorazio PM (2017) Radiotherapy for stage I and II testicular seminomas: secondary malignancies and survival. Urol Oncol 35:606.e1\u2013606.e7","journal-title":"Urol Oncol"},{"key":"2965_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/annonc\/mdm540","volume":"19","author":"T Powles","year":"2008","unstructured":"Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T (2008) The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 19:443\u2013447","journal-title":"Ann Oncol"},{"issue":"5 Pt 2","key":"2965_CR26","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1111\/j.1365-2605.2010.01123.x","volume":"34","author":"G P\u00fchse","year":"2011","unstructured":"P\u00fchse G, Secker A, Kemper S, Hertle L, Kliesch S (2011) Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment. Int J Androl 34(5 Pt 2):e351\u2013e357","journal-title":"Int J Androl"},{"issue":"10029","key":"2965_CR27","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/S0140-6736(15)00991-5","volume":"387","author":"E Rajpert-De Meyts","year":"2016","unstructured":"Rajpert-De Meyts E, McGlynn KA, Okamoto K, Jewett MA, Bokemeyer C (2016) Testicular germ cell tumours. Lancet 387(10029):1762\u20131774","journal-title":"Lancet"},{"key":"2965_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0090-4295(98)00139-3","volume":"52","author":"WJ Reiter","year":"1998","unstructured":"Reiter WJ, Kratzik C, Brodowicz T, Haitel A, Pokorny A, Zielinski CC, Marberger M (1998) Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Urology 52:117\u2013119","journal-title":"Urology"},{"key":"2965_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1200\/JCO.2001.19.1.101","volume":"19","author":"WJ Reiter","year":"2001","unstructured":"Reiter WJ, Brodowicz T, Alavi S, Zielinski CC, Kozak W, Maier U, N\u00f6st G, Lipsky H, Marberger M, Kratzik C (2001) Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma. J Clin Oncol 19:101\u2013104","journal-title":"J Clin Oncol"},{"key":"2965_CR30","doi-asserted-by":"publisher","unstructured":"Robert Koch Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland (2015) Krebs in Deutschland 2011\/12, 10. Ausgabe. Robert Koch Institut, Berlin. \n                    https:\/\/doi.org\/10.17886\/rkipubl-2015-004","DOI":"10.17886\/rkipubl-2015-004"},{"issue":"1","key":"2965_CR31","doi-asserted-by":"publisher","first-page":"33.e1","DOI":"10.1016\/j.urolonc.2012.12.002","volume":"32","author":"CG Ruf","year":"2014","unstructured":"Ruf CG, Isbarn H, Wagner W, Fisch M, Matthies C, Dieckmann KP (2014) Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. Urol Oncol 32(1):33.e1\u201333.e6","journal-title":"Urol Oncol"},{"issue":"7","key":"2965_CR32","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1464-410X.2010.09658.x","volume":"107","author":"H Steiner","year":"2011","unstructured":"Steiner H, Scheiber K, Berger AP, Rein P, Hobisch A, Aufderklamm J, Pilloni S, Stoehr B, Aigner F, Fritzer A, Zangerl F (2011) Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma. BJU Int 107(7):1074\u20131079","journal-title":"BJU Int"},{"issue":"11","key":"2965_CR33","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s12094-017-1742-y","volume":"9","author":"A Terbuch","year":"2017","unstructured":"Terbuch A, Posch F, Annerer LM, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Partl R, Kapp KS, St\u00f6ger H, Gerger A, Stotz M (2017) Long-term cardiovascular complications in stage I seminoma patients. Clin Transl Oncol 9(11):1400\u20131408","journal-title":"Clin Transl Oncol"},{"key":"2965_CR34","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"LB Travis","year":"2005","unstructured":"Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JDJ, Dores GM, Gilbert ES (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97:1354\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"2965_CR35","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","volume":"25","author":"AW van den Belt-Dusebout","year":"2007","unstructured":"van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25:4370\u20134378","journal-title":"J Clin Oncol"},{"issue":"9","key":"2965_CR36","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00120-013-3319-x","volume":"52","author":"F Zengerling","year":"2013","unstructured":"Zengerling F, M\u00fcller J, Schrader AJ, Schrader M (2013) Clinical stage I seminoma: is surveillance a new therapy standard? [Article in German]. Urologe A 52(9):1265\u20131269","journal-title":"Urologe A"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02965-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:09:52Z","timestamp":1594076992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02965-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2965"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02965-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"27 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors declare any conflicts of interest related to the present report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study received approval from the ethical committee of the \u00c4rztekammer Hamburg (PV5025\/2015). All procedures performed in this study were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}